Security key
000899104
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 238,388,839
- Total 13F shares
- 8,453,450
- Share change
- -457,610
- Total reported value
- $26,039,000
- Price per share
- $3.08
- Number of holders
- 17
- Value change
- -$2,115,756
- Number of buys
- 7
- Number of sells
- 7
Report period
Q3 2017
Institutions
17
Top holders
10
ADMA full security history
Newer quarter: Q4 2017
Previous quarter: Q2 2017
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$13,350,000 | — | 30 Jun 2017 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.6%
|
1,433,304
|
$5,303,000 | — | 30 Jun 2017 | |
| Consonance Capital Management LP |
13F
|
Company |
0.53%
|
1,273,933
|
$4,714,000 | — | 30 Jun 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.3%
|
721,102
|
$2,769,000 | — | 30 Jun 2017 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.29%
|
681,346
|
$2,521,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
0.16%
|
387,500
|
$1,488,000 | — | 30 Jun 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
348,870
|
$1,340,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.06%
|
150,028
|
$576,000 | — | 30 Jun 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.06%
|
150,000
|
$555,000 | — | 30 Jun 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
35,147
|
$130,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
21,526
|
$82,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
21,344
|
$79,000 | — | 30 Jun 2017 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.01%
|
20,000
|
$74,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
16,856
|
$62,000 | — | 30 Jun 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0%
|
11,300
|
$42,000 | — | 30 Jun 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0%
|
10,700
|
$39,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0%
|
10,555
|
$39,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
8,237
|
$31,000 | — | 30 Jun 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,141
|
$4,000 | — | 30 Jun 2017 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q3 2017
As of 30 Sep 2017,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,453,450 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, PERCEPTIVE ADVISORS LLC, Iguana Healthcare Management, LLC, FMR LLC, VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
19
Q3 2017 holders
17
Holder diff
-2
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.